Search

everythinglearnresearchcommunity

for

Search:↓

Higher early lead exposure is linked to delayed puberty in girls.

Low selenium intake may delay puberty in boys but not in girls.

Hydroxychloroquine may help delay skin damage in lupus patients.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

5α-Reductase inhibitors may increase depression risk but not dementia or suicide.

Researchers found two new genetic variants linked to Alzheimer's disease.

CEC levels may be a useful marker for predicting prostate cancer progression.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Pantethine may boost the immune system's ability to fight sarcoma.

A mother's diet at conception can cause lasting genetic changes in her child.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Gene variation affects prostate issues and hair loss.

A new gene, JMJD1C, may affect testosterone levels in men.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

PRP treatment helps hair growth and reduces hair loss in women, but more research needed.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Older men with low levels of a testosterone byproduct had a higher chance of developing an irregular heartbeat.

More high-quality research is needed to recommend flavonoids and saponins for clinical use.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

Autism's genetics are linked with early age of puberty and less hair loss, but not with hormone levels or polycystic ovary syndrome.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.